Press Release
Bayir, Inc., A New Jersey-based manufacturer of premium quality ingredients for the dietary supplement, functional food and beverage and nutraceutical industries, recently announced the approval of a process patent synthesizing curcumin nanoparticles. The nanoparticles are developed using Bayir's in-house technology. This patenet approval holds great promise for formulators, offering more versatility in applications of curcumin.
"The new patent offers ground-breaking applications for formulators," said B.G. Bairy, Chairman and Managing Director of the Bayir Group. "We have been testing nano particle applications for a number of years, the impetus being the increasing demand from the consumer market for innovative applications of curcumin. The market has really pressed on the need for more bioavailable and readily soluble forms. The new nano-particle formulation, along with the micronized product variants technology, allows for more diverse and 'user-friendly' applications, including food, beverage and OTC formulations."
Bayir uses sophisticated extraction process to obtain the purest and most concentrated forms of their organic ingredients, including curcumin. The company maintains nine manufacturing facilities worldwide with specialties including bacopa, glucosamine, chondroitin, organic extracts, and a wide range of botanicals such as garcinia cambogia.
Bayir, Inc. actively supports the "Bayir Gold" program, which enforces a top-level priority of the accountability and traceability with an interest in upholding a higher standard of quality, safety and accountability in the ingredient marketplace. For more information on Bayir Inc., please visit them at booth #Q168 at SupplySide Weset in Las Vegas, Nevada next week. Please contact [email protected] for more details.